Authors:
Patterson, LJ
Robey, F
Muck, A
Van Remoortere, K
Aldrich, K
Richardson, E
Alvord, WG
Markham, PD
Cranage, M
Robert-Guroff, M
Citation: Lj. Patterson et al., A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge, AIDS RES H, 17(9), 2001, pp. 837-849
Authors:
Cheng, JG
Chen, JR
Hernandez, L
Alvord, WG
Stewart, CL
Citation: Jg. Cheng et al., Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation, P NAS US, 98(15), 2001, pp. 8680-8685
Authors:
Kuhns, DB
Nelson, EL
Alvord, WG
Gallin, JI
Citation: Db. Kuhns et al., Fibrinogen induces IL-8 synthesis in human neutrophils stimulated with formyl-methionyl-leucyl-phenylalanine or leukotriene B-4, J IMMUNOL, 167(5), 2001, pp. 2869-2878
Authors:
Arun, B
Curti, BD
Longo, DL
Stevens, D
Alvord, WG
Gause, BL
Watson, T
Kopp, WC
Janik, JE
Citation: B. Arun et al., Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia, CA J SCI AM, 6(1), 2000, pp. 21-24
Authors:
Shiao, YH
Palli, D
Caporaso, NE
Alvord, WG
Amorosi, A
Nesi, G
Saieva, C
Masala, G
Fraumeni, JF
Rice, JM
Citation: Yh. Shiao et al., Genetic and immunohistochemical analyses of p53 independently predict regional metastasis of gastric cancers, CANC EPID B, 9(6), 2000, pp. 631-633
Authors:
Patterson, LJ
Peng, B
Abimiku, AG
Aldrich, K
Murty, L
Markham, PD
Kalyanaraman, VS
Alvord, WG
Tartaglia, J
Franchini, G
Robert-Guroff, M
Citation: Lj. Patterson et al., Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques, AIDS, 14(16), 2000, pp. 2445-2455
Authors:
Lempicki, RA
Kovacs, JA
Baseler, MW
Adelsberger, JW
Dewar, RL
Natarajan, V
Bosche, MC
Metcalf, JA
Stevens, RA
Lambert, LA
Alvord, WG
Polis, MA
Davey, RT
Dimitrov, DS
Lane, HC
Citation: Ra. Lempicki et al., Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4(+) and CD8(+) T cell turnover in HIV-infected patients, P NAS US, 97(25), 2000, pp. 13778-13783
Authors:
Koo, HM
Gray-Goodrich, M
Kohlhagen, G
McWilliams, MJ
Jeffers, M
Vaigro-Wolff, A
Alvord, WG
Monks, A
Paull, KD
Pommier, Y
Vande Woude, GF
Citation: Hm. Koo et al., The ras oncogene-mediated sensitization of human cells to topoisomerase IIinhibitor-induced apoptosis, J NAT CANC, 91(3), 1999, pp. 236-244
Authors:
Janik, JE
Miller, LL
Kopp, WC
Taub, DD
Dawson, H
Stevens, D
Kostboth, P
Curti, BD
Conlon, KC
Dunn, BK
Donegan, SE
Ullrich, R
Alvord, WG
Gause, BL
Longo, DL
Citation: Je. Janik et al., Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients, CLIN IMMUNO, 93(3), 1999, pp. 209-221
Authors:
Tsarfaty, I
Alvord, WG
Resau, JH
Altstock, RT
Lidereau, R
Bieche, I
Bertrand, F
Horev, J
Klabansky, RL
Keydar, I
Vande Woude, GF
Citation: I. Tsarfaty et al., Alteration of Met protooncogene product expression and prognosis in breastcarcinomas, ANAL QUAN C, 21(5), 1999, pp. 397-408
Authors:
Highbarger, HC
Alvord, WG
Jiang, MK
Shah, AS
Metcalf, JA
Lane, HC
Dewar, RL
Citation: Hc. Highbarger et al., Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples, J CLIN MICR, 37(11), 1999, pp. 3612-3614
Authors:
Fritz, RS
Hayden, FG
Calfee, DP
Cass, LMR
Peng, AW
Alvord, WG
Strober, W
Straus, SE
Citation: Rs. Fritz et al., Nasal cytokine and chemokine responses in experimental influenza A virus infection: Results of a placebo-controlled trial of intravenous zanamivir treatment, J INFEC DIS, 180(3), 1999, pp. 586-593